Chuck Ence insider trades
Open-market stock purchases and sales by Chuck Ence, CA and CO at Relmada Therapeutics, Inc, from SEC Form 4 filings since Dec 19, 2019.
Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +76%.
Companies traded
- RLMD Relmada Therapeutics, Inc: 5 buys, last Dec 12, 2025